Results 271 to 280 of about 553,015 (386)

Early‐stage health technology assessment of a curative gene therapy for multiple sclerosis

British Journal of Clinical Pharmacology, EarlyView.
Aims Multiple sclerosis (MS) is associated with significant early morbidity, reduced life expectancy and substantial healthcare and societal costs. The primary objective of this study is to assess the early cost‐effectiveness potential of a novel gene therapy, IMMUTOL, for MS compared with current high‐efficacy treatment sequences.
Attila Imre, Balázs Nagy, Rok Hren
wiley   +1 more source

Investigating whether socially acquired nocebo effects can spread to other treatments. [PDF]

Sci Rep
Saunders C, Tan W, Barnes K, McNair N, Colagiuri B.   +4 more
europepmc   +1 more source

Library Holiday Hours, Subscription to Microbiology, JAMA & Archives, Vol 9 (11) [PDF]

, 2011
Texas Medical Center Library
core   +1 more source

A randomized, placebo-controlled trial of diindolylmethane for breast cancer biomarker modulation in patients taking tamoxifen

, 2017
Cynthia A. Thomson, H.‐H. Sherry Chow, Betsy C. Wertheim, Denise J. Roe, Alison Stopeck, Gertraud Maskarinec, María I. Altbach, Pavani Chalasani, Chuan Huang, M. Ström, Jean-Philippe Galons, Patricia A. Thompson   +11 more
openalex   +2 more sources

Drugs and placebos: what's the difference?

EMBO Reports, 2014
F. Benedetti
semanticscholar   +1 more source

Adverse immunostimulation in early phase clinical trials: Key findings and recommendations based on the investigator's clinical experience

British Journal of Clinical Pharmacology, EarlyView.
Problem setting The emergence of therapeutic proteins has coincided with an increase of acute adverse immunostimulation (AIS). AIS has occured in clinical trials despite compliance with regulatory guidelines on preclinical evaluation and its incidence is anticipated to increase even further.
Juliette A. van den Noort, Marella C. E. van Ruissen, Lisanne C. A. Smidt, Naomi B. Klarenbeek, Philip H. K. Kremer, Manon A. A. Jansen, Jacobus Burggraaf, Joop M. A. van Gerven, Matthijs Moerland   +8 more
wiley   +1 more source

Genicular Nerve Block as an Effective Treatment for Knee Pain: Addressing Variability and Enhancing Meta-Analysis Reliability [Letter]. [PDF]

J Pain Res
Liu J, Wen C, Xu L.
europepmc   +1 more source

Pentoxifylline dose finding trial in preterm neonates with suspected late onset sepsis (PTX‐trial)

British Journal of Clinical Pharmacology, EarlyView.
Aim The aim of this study (PTX‐trial) is to determine the optimal dose of pentoxifylline (PTX) in preterm neonates (gestational age < 30 weeks) with (suspected) late onset sepsis (LONS). Methods The PTX‐trial is a prospective multicentre open‐label sequential dose‐optimization study with an adapted continual reassessment method.
Serife Kurul, H. Rob Taal, Jan Mazela, Ryszard Lauterbach, Irwin K. M. Reiss, Karel Allegaert, Robert B. Flint, Sinno H. P. Simons   +7 more
wiley   +1 more source

How do placebos work?

European Journal of Psychotraumatology, 2018
Fabrizio Benedetti, Alessandro Piedimonte, Elisa Frisaldi   +2 more
doaj   +1 more source

Open label placebo to treat fatigue in people with multiple sclerosis: feasibility and preliminary effects. [PDF]

Pilot Feasibility Stud
Baidwan NK, Tracy T, Chiu CY, Nawshin T, Hoenemeyer T, Riser E, Motl R, Fontaine K, Mehta T.   +8 more
europepmc   +1 more source